Literature DB >> 30882192

Uric acid and xantine-oxidase inhibitors in patients with gout: A re-assessment and an update.

Claudio Borghi1, Krzysztof Narkiewicz2, Giuseppe Mancia3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30882192      PMCID： PMC8086684          DOI： 10.5603/CJ.2019.0015

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  13 in total

Review 1.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 2.  Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk.

Authors:  Claudio Borghi; Andrzej Tykarski; Krystyna Widecka; Krzysztof J Filipiak; Justyna Domienik-Karłowicz; Katarzyna Kostka-Jeziorny; Albert Varga; Milosz Jaguszewski; Krzysztof Narkiewicz; Giuseppe Mancia
Journal:  Cardiol J       Date:  2018       Impact factor: 2.737

3.  Gout, Xanthine Oxidase Inhibition, and Cardiovascular Outcomes.

Authors:  William B White
Journal:  Circulation       Date:  2018-09-11       Impact factor: 29.690

Review 4.  Cardiac and renal protective effects of urate-lowering therapy.

Authors:  Pascal Richette; Augustin Latourte; Thomas Bardin
Journal:  Rheumatology (Oxford)       Date:  2018-01-01       Impact factor: 7.580

Review 5.  Definition of hyperuricemia and gouty conditions.

Authors:  Thomas Bardin; Pascal Richette
Journal:  Curr Opin Rheumatol       Date:  2014-03       Impact factor: 5.006

Review 6.  Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis.

Authors:  C Borghi; F Perez-Ruiz
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-03       Impact factor: 3.507

7.  Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.

Authors:  William B White; Kenneth G Saag; Michael A Becker; Jeffrey S Borer; Philip B Gorelick; Andrew Whelton; Barbara Hunt; Majin Castillo; Lhanoo Gunawardhana
Journal:  N Engl J Med       Date:  2018-03-12       Impact factor: 91.245

Review 8.  Uric acid, evolution and primitive cultures.

Authors:  Richard J Johnson; Srinivas Titte; J Robert Cade; Bruce A Rideout; William J Oliver
Journal:  Semin Nephrol       Date:  2005-01       Impact factor: 5.299

Review 9.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Authors:  Richard J Johnson; George L Bakris; Claudio Borghi; Michel B Chonchol; David Feldman; Miguel A Lanaspa; Tony R Merriman; Orson W Moe; David B Mount; Laura Gabriella Sanchez Lozada; Eli Stahl; Daniel E Weiner; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2018-02-27       Impact factor: 8.860

10.  Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.

Authors:  MaryAnn Zhang; Daniel H Solomon; Rishi J Desai; Eun Ha Kang; Jun Liu; Tuhina Neogi; Seoyoung C Kim
Journal:  Circulation       Date:  2018-09-11       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.